| Pharmaceuticals Industry | Healthcare Sector | - CEO | KRX SM Exchange | - ISIN |
| KR Country | 178 Employees | 27 Dec 2024 Last Dividend | - Last Split | - IPO Date |
KUKJEON PHARMACEUTICAL Co., Ltd, established in 1972, positions itself as a comprehensive chemical solutions provider within South Korea. Focusing on a broad array of chemical-based products and services, the company integrates after-sales support including research and development, production, quality control, and Drug Master File (DMF) services into its operations. Standing at the forefront of innovation, KUKJEON PHARMACEUTICAL has secured several patents for its unique manufacturing methods, underlining its commitment to excellence and innovation in the chemical industry. With its headquarters located in Anyang-si, South Korea, the company plays a pivotal role in supplying critical resources across various sectors including pharmaceuticals, intermediate products, new drug synthesis, and related materials industries.
KUKJEON PHARMACEUTICAL specializes in the manufacture of Active Pharmaceutical Ingredients, vital for the production of a wide range of medications. This offering is complemented by molecular design and technical support services, ensuring that partners have access to the highest quality materials backed by expert guidance.
The company develops specialized electronic materials including antistatic agents, monomers, and polymers with low dielectric constants, along with UV curing agents. These innovative products find applications in various high-tech industries, demonstrating KUKJEON PHARMACEUTICAL’s capability in bridging chemical solutions with technological advancements.
With a focus on the electronics industry, the company produces low-resistance electrolyte solutions, as well as unique phosphine, silane, and boron compounds. These specialized chemicals are essential for the development and manufacture of semiconductors and other critical components.
Semiconductor materials produced by KUKJEON PHARMACEUTICAL are designed to meet the stringent requirements of the electronic and technology sectors, further solidifying the company's position as a key player in the supply chain of semiconductor manufacturing.
The company provides a diverse range of intermediates such as carbazole, boric acid, and fluorene. These intermediates are crucial for the synthesis of various organic compounds, reflecting the company's vast expertise and innovative capabilities in chemical synthesis.